Artificial heart

BiVACOR® Receives $13 Million to Support Clinical Trials for the Company’s Total Artificial Heart

Retrieved on: 
Tuesday, February 20, 2024
Health, Medical Devices, Surgery, Health Technology, General Health, Clinical Trials, Cardiology, The Alfred Hospital, USD, Multimedia, University of Queensland, The Texas Heart Institute, University, FDA, Cancer, Hospital, IDE, Artificial heart, Griffith University, Heart failure, MRFF, Fatigue, TAH, Patient, Monash University, Survival, Periodic breathing, EFS, Pharmaceutical industry

BiVACOR® , a clinical-stage medical device company, today announced $13 million (USD) awarded from the Australian Government’s Medical Research Future Fund (MRFF) grant through the Artificial Heart Frontiers Program (AHFP) to support BiVACOR’s Total Artificial Heart program and future product enhancements.

Key Points: 
  • BiVACOR® , a clinical-stage medical device company, today announced $13 million (USD) awarded from the Australian Government’s Medical Research Future Fund (MRFF) grant through the Artificial Heart Frontiers Program (AHFP) to support BiVACOR’s Total Artificial Heart program and future product enhancements.
  • View the full release here: https://www.businesswire.com/news/home/20240220429887/en/
    BiVACOR® Total Artificial Heart (TAH) in Surgeon's Hands (Photo: Business Wire)
    Led by Monash University, the AHFP is comprised of a consortium of research centers in Australia in collaboration with BiVACOR.
  • The award will support clinical work of the BiVACOR Total Artificial Heart (TAH) and begin development for the integration of wireless power sources for the device.
  • “There is a huge gap between available treatment options and the number of patients with severe heart failure.

Heart Pump Device Market by Product, Type, Therapy and Region - Global Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 9, 2021
Medical devices, Health, Cardiology, Interventional cardiology, Medical specialties, Medicine, Medical devices, Clinical medicine, Prosthetics, Ventricular assist device, Artificial heart, Destination therapy, Thoratec, Abiomed

The global heart pump device market is projected to reach USD 5.5 billion by 2026 from USD 2.1 billion in 2021, at a CAGR of 21.6% from 2021 to 2026.

Key Points: 
  • The global heart pump device market is projected to reach USD 5.5 billion by 2026 from USD 2.1 billion in 2021, at a CAGR of 21.6% from 2021 to 2026.
  • Ventricular assist devices are expected to hold the largest share of the heart pump device market, by product in 2021
    Based on products, the heart pump devices market is segmented into ventricular assist devices, intra- aortic balloon pumps, and total artificial hearts.
  • Implantable heart pump devices are expected to hold the largest share of the heart pump device market, by type in 2021
    Based on type, the market is segmented into implantable heart pump devices and extracorporeal heart pump devices.
  • Bridge-to-transplant is expected to hold the largest share of the heart pump device market, by therapy in 2021
    Based on therapy, the market is segmented into bridge-to-transplant (BTT), bridge-to-candidacy (BTC), destination therapy (DT), and other therapies.

Global Prosthetic Heart Valve/Artificial Heart Valve Market Trends, Forecast, and Competitive Analysis Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 20, 2021
Medical devices, Health, Medicine, Medical specialties, Cardiology, Clinical medicine, Cardiac surgery, Prosthetics, Artificial heart valve, Edwards Lifesciences, Prosthesis, Valvular heart disease, LivaNova, Artificial heart

b'The "Prosthetic Heart Valve/Artificial Heart Valve Market Report: Trends, Forecast, and Competitive Analysis" report has been added to ResearchAndMarkets.com\'s offering.\nThe global prosthetic heart valve/artificial heart valve market is expected to grow with a CAGR of 13% from 2019 to 2024.\nThe future of the prosthetic heart valve/artificial heart valve market looks promising with opportunities in the cardiovascular applications.

Key Points: 
  • b'The "Prosthetic Heart Valve/Artificial Heart Valve Market Report: Trends, Forecast, and Competitive Analysis" report has been added to ResearchAndMarkets.com\'s offering.\nThe global prosthetic heart valve/artificial heart valve market is expected to grow with a CAGR of 13% from 2019 to 2024.\nThe future of the prosthetic heart valve/artificial heart valve market looks promising with opportunities in the cardiovascular applications.
  • The major growth drivers for this market are increasing geriatric population, growing frequency of structural heart diseases, technological advancement, and rising awareness on heart valve diseases.\nThe study includes the prosthetic heart valve/artificial heart valve market size and forecast for the global prosthetic heart valve/artificial heart valve market through 2024, segmented by valve type and region.\nSome of the prosthetic heart valve/artificial heart valve companies profiled in this report include Medtronic, Edwards Lifesciences, Boston Scientific, Livanova, St. Jude Medical, Symetis, Jenavalve Technology, Cryolife, TTK Healthcare, Colibri Heart Valve, Lepu Medical Technology, and Braile Biomedica.\nSome of the features of \'Global Prosthetic Heart Valve/Artificial Heart Valve Market 2019-2024: Trends, Forecast, and Opportunity Analysis\' include:\nMarket size estimates: Global prosthetic heart valve/artificial heart valve market size estimation in terms of value ($M) shipment.\nTrend and forecast analysis: Market trend (2013-2018) and forecast (2019-2024) by segments and region.\nSegmentation analysis: Global market size by valve type and region.\nRegional analysis: Global prosthetic heart valve/artificial heart valve market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.\nGrowth opportunities: Analysis on growth opportunities in different applications and regions for prosthetic heart valve/artificial heart valve in the global prosthetic heart valve/artificial heart valve market.\nStrategic analysis: This includes M&A, new product development, and competitive landscape for, prosthetic heart valve/artificial heart valve in the global prosthetic heart valve/artificial heart valve market.\nAnalysis of competitive intensity of the industry based on Porter\'s Five Forces model.\nThis report answers the following 11 key questions:\nWhat are some of the most promising potential, high-growth opportunities for the global prosthetic heart valve/artificial heart valve market?\nWhich segments will grow at a faster pace and why?\nWhich regions will grow at a faster pace and why?\nWhat are the key factors affecting market dynamics?
  • What are the drivers and challenges of the prosthetic heart valve/artificial heart valve market?\nWhat are the business risks and threats to the prosthetic heart valve/artificial heart valve market?\nWhat are emerging trends in this prosthetic heart valve/artificial heart valve market and the reasons behind them?\nWhat are some changing demands of customers in the prosthetic heart valve/artificial heart valve market?\nWhat are the new developments in the prosthetic heart valve/artificial heart valve market?
  • What strategic initiatives are being implemented by key players for business growth?\nWhat are some of the competitive products and processes in this prosthetic heart valve/artificial heart valve area and how big of a threat do they pose for loss of market share via material or product substitution?\nWhat M & A activities have taken place in the last 5 years in prosthetic heart valve/artificial heart valve market?\n3.2: Global Prosthetic Heart Valve/Artificial Heart Valve Market: Trends and Forecast\n'

France Prosthetic Heart Valves Market Outlook to 2025 - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves

Retrieved on: 
Wednesday, November 18, 2020
Medical specialties, Medicine, Cardiology, Clinical medicine, Cardiac surgery, Prosthetics, Artificial heart valve, Prosthesis, Heart valve, Artificial heart

"France Prosthetic Heart Valves Market Outlook to 2025" is a comprehensive databook report, covering key market data on the France Prosthetic Heart Valves market.

Key Points: 
  • "France Prosthetic Heart Valves Market Outlook to 2025" is a comprehensive databook report, covering key market data on the France Prosthetic Heart Valves market.
  • The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves.
  • - 2019 company share and distribution share data for Prosthetic Heart Valves Market.
  • - Global corporate-level profiles of key companies operating within the France Prosthetic Heart Valves Market.

Artificial Organs Market Revenue to Cross USD 33.5 Bn by 2026: Global Market Insights, Inc.

Retrieved on: 
Thursday, November 5, 2020
Prosthetics, Medicine, Medical specialties, Clinical medicine, Artificial organ, Testicle, Artificial kidney, Organ, Artificial heart, Automated insulin delivery systems

SELBYVILLE, Del., Nov. 5, 2020 /PRNewswire/ -- According to the latest report "Artificial Organs Market by Organ Type (Artificial Kidney, Artificial Liver, Artificial Lungs, Artificial Pancreas, Artificial Heart), By Material Type (Silicon, Plastic, Steel), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2026", by Global Market Insights, Inc., the market valuation of artificial organs will cross $33.5 billion by 2026.

Key Points: 
  • SELBYVILLE, Del., Nov. 5, 2020 /PRNewswire/ -- According to the latest report "Artificial Organs Market by Organ Type (Artificial Kidney, Artificial Liver, Artificial Lungs, Artificial Pancreas, Artificial Heart), By Material Type (Silicon, Plastic, Steel), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2026", by Global Market Insights, Inc., the market valuation of artificial organs will cross $33.5 billion by 2026.
  • Artificial organs offer an effective solution to minimize the death burden due to the unavailability of organs.
  • Along with the incidence of organ dysfunction, technological advancements in artificial organ devices are expected to fuel the artificial organs market expansion.
  • The artificial kidney segment dominated more than 50% of the artificial organs market share in 2019, led by significantly increasing kidney failures.

Worldwide Mechanical Heart Valves Industry to 2024 - Competitor Sales and Market Share - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 10, 2020
Health, Medical devices, Cardiology, Cardiology, Medicine, Medical specialties, Articles, Cardiac surgery, Business process, Artificial heart valve, Prosthetics, Artificial heart, Prosthesis, Medical device, Market analysis

The "Global Mechanical Heart Valves Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Mechanical Heart Valves Market" report has been added to ResearchAndMarkets.com's offering.
  • This report was developed using extensive primary and secondary research by the publisher's analysts.
  • Data from proprietary databases, proprietary market reports, company reports, import/export databases, and secondary data sources on medical device markets were used to develop estimates of 2019 worldwide market size by product segment, ASPs, sales, and market share for the top suppliers by product segment.
  • Devices in this global market analysis include prosthetic heart valves implanted in open surgery.

SDU Researchers Develop ECMO Proto Device in Aid of Fighting COVID-19

Retrieved on: 
Monday, July 27, 2020
Medical equipment, Extracorporeal membrane oxygenation, Intensive care medicine, Membrane technology, Medicine, Artificial heart, Health care, Health

Professor Liu Shuqins Team in Shandong University, China announced their recent achievements in developing a proto-type ECMO equipment.

Key Points: 
  • Professor Liu Shuqins Team in Shandong University, China announced their recent achievements in developing a proto-type ECMO equipment.
  • Since 2008, the team has been studying the maglev artificial heart pumpthe core component of ECMO.
  • Thus ECMO is regarded as a "life-saving device" enabling medical staff to race against time in saving patients lives.
  • The researchers hope the production of the ECMO equipment could provide help to people in urgent needs around the world.

Insights & Forecast with Potential Impact of COVID-19 - Artificial Organs Market 2020-2024 | Increasing Prevalence of Chronic Disorders to Boost Growth | Technavio

Retrieved on: 
Thursday, June 25, 2020
Health, General Health, Articles, Technology, Academic disciplines, Artificial heart, Cardiology, Benchmarking, Artificial intelligence, Market, Artificial organ

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR44011

Key Points: 
  • To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR44011
    Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources.
  • Our artificial organs market report covers the following areas:
    This study identifies the emergence of total artificial hearts (TAH) as one of the prime reasons driving the artificial organs market growth during the next few years.
  • Backed with competitive intelligence and benchmarking, our research reports on the artificial organs market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • Register for a free trial today and gain instant access to 17,000+ market research reports.

Face Shields for Medical Staff Now Available from SynCardia Systems, LLC

Retrieved on: 
Thursday, April 9, 2020
Cardiology, Medical specialties, Clothing, SynCardia Systems, Medicine, Artificial heart, Shield, Face shield

Made from the highly transparent and durable thermoplastic PETG, the face shields provide a high degree of protection in a light weight, high visibility form factor.

Key Points: 
  • Made from the highly transparent and durable thermoplastic PETG, the face shields provide a high degree of protection in a light weight, high visibility form factor.
  • The systems lay flat design allows for large quantities of shields to be shipped and stored in a space efficient manner.
  • A limited supply of face shields is available now with additional stock to follow.
  • SynCardia Systems, LLC (Tucson, AZ) is the privately-held manufacturer of the worlds first and only FDA, Health Canada and CE approved temporary Total Artificial Heart.

80% Ethanol Hand Sanitizer Now Available from SynCardia Systems, LLC

Retrieved on: 
Monday, April 6, 2020
Branches of biology, Health, Chemical substances, Hygiene, Cardiology, Disinfectants, Hepatotoxins, Teratogens, SynCardia Systems, Hand sanitizer, Artificial heart, Hand washing

SynCardia is now offering 80% ethanol hand sanitizer for sale in bulk quantities intended for hospitals and other large healthcare organizations as well as food service and federal, state, and local agencies capable of distributing to the areas of greatest need

Key Points: 
  • SynCardia is now offering 80% ethanol hand sanitizer for sale in bulk quantities intended for hospitals and other large healthcare organizations as well as food service and federal, state, and local agencies capable of distributing to the areas of greatest need
    SynCardia Systems, LLC announced today that the company has begun manufacturing and selling an 80% ethanol (alcohol) hand sanitizer.
  • Hand hygiene is an important part of the U.S. response to COVID-19.
  • SynCardia Systems, LLC (Tucson, AZ) is the privately-held manufacturer of the worlds first and only FDA, Health Canada and CE approved temporary Total Artificial Heart.
  • Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency.